Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C TOFFOLI

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Journal for Immunotherapy of Cancer|December 6, 2023
Allogeneic NK cells induce monocyte-to-dendritic cell conversion, control tumor growth, and trigger a pro-inflammatory shift in patient-derived cultures of primary and metastatic colorectal cancerElisa C Toffoli, Amanda A van Vliet, Henk W M Verheul, et al.
Mediators of Inflammation|January 1, 1997
The neutrophil migration induced by tumour necrosis factor alpha in mice is unaffected by glucocorticoidsC A Cecilio, E H Costa, P Ucelli, et al.
Physiological Reports|June 10, 2021
Effects of physical exercise on natural killer cell activity during (neo)adjuvant chemotherapy: A randomized pilot studyElisa C Toffoli, Maike G Sweegers, Hetty J Bontkes, et al.
Cancers|February 12, 2021
Natural Killer Cells and Anti-Cancer Therapies: Reciprocal Effects on Immune Function and Therapeutic ResponseElisa C Toffoli, Abdolkarim Sheikhi, Yannick D Höppner, et al.
Clinical and Experimental Immunology|February 8, 2024
Allogeneic NK cells induce the in vitro activation of monocyte-derived and conventional type-2 dendritic cells and trigger an inflammatory response under cancer-associated conditionsE C Toffoli, A A van Vliet, C Forbes, et al.
Bioorganic Chemistry|December 27, 2021
Anti-inflammatory, ulcerogenic and platelet activation evaluation of novel 1,4-diaryl-1,2,3-triazole neolignan-celecoxib hybridsJosyelen L Felipe, Tatiana B Cassamale, Leticia D Lourenço, et al.
Cancers|November 13, 2021
Enhancement of NK Cell Antitumor Effector Functions Using a Bispecific Single Domain Antibody Targeting CD16 and the Epidermal Growth Factor ReceptorElisa C Toffoli, Abdolkarim Sheikhi, Roeland Lameris, et al.
Plos One|February 25, 2015
Optimization and technological development strategies of an antimicrobial extract from Achyrocline alata assisted by statistical designDaniel P Demarque, Sonia Maria F Fitts, Amanda G Boaretto, et al.
BMC Cancer|November 10, 2019
Incidence and risk factors for acute kidney injury in head and neck cancer patients treated with concurrent chemoradiation with high-dose cisplatinMaurice J D L van der Vorst, Elisabeth C W Neefjes, Elisa C Toffoli, et al.
Oncoimmunology|May 7, 2026
Sex-based considerations in the choice for a TLR9 or TLR7/8 agonist to arm the sentinel lymph node in early-stage melanomaJessica C L Notohardjo, Elisa C Toffoli, Tara Muijlwijk, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Journal for Immunotherapy of Cancer|December 6, 2023
Allogeneic NK cells induce monocyte-to-dendritic cell conversion, control tumor growth, and trigger a pro-inflammatory shift in patient-derived cultures of primary and metastatic colorectal cancerElisa C Toffoli, Amanda A van Vliet, Henk W M Verheul, et al.
Mediators of Inflammation|January 1, 1997
The neutrophil migration induced by tumour necrosis factor alpha in mice is unaffected by glucocorticoidsC A Cecilio, E H Costa, P Ucelli, et al.
Physiological Reports|June 10, 2021
Effects of physical exercise on natural killer cell activity during (neo)adjuvant chemotherapy: A randomized pilot studyElisa C Toffoli, Maike G Sweegers, Hetty J Bontkes, et al.
Cancers|February 12, 2021
Natural Killer Cells and Anti-Cancer Therapies: Reciprocal Effects on Immune Function and Therapeutic ResponseElisa C Toffoli, Abdolkarim Sheikhi, Yannick D Höppner, et al.
Clinical and Experimental Immunology|February 8, 2024
Allogeneic NK cells induce the in vitro activation of monocyte-derived and conventional type-2 dendritic cells and trigger an inflammatory response under cancer-associated conditionsE C Toffoli, A A van Vliet, C Forbes, et al.
Bioorganic Chemistry|December 27, 2021
Anti-inflammatory, ulcerogenic and platelet activation evaluation of novel 1,4-diaryl-1,2,3-triazole neolignan-celecoxib hybridsJosyelen L Felipe, Tatiana B Cassamale, Leticia D Lourenço, et al.
Cancers|November 13, 2021
Enhancement of NK Cell Antitumor Effector Functions Using a Bispecific Single Domain Antibody Targeting CD16 and the Epidermal Growth Factor ReceptorElisa C Toffoli, Abdolkarim Sheikhi, Roeland Lameris, et al.
Plos One|February 25, 2015
Optimization and technological development strategies of an antimicrobial extract from Achyrocline alata assisted by statistical designDaniel P Demarque, Sonia Maria F Fitts, Amanda G Boaretto, et al.
BMC Cancer|November 10, 2019
Incidence and risk factors for acute kidney injury in head and neck cancer patients treated with concurrent chemoradiation with high-dose cisplatinMaurice J D L van der Vorst, Elisabeth C W Neefjes, Elisa C Toffoli, et al.
Oncoimmunology|May 7, 2026
Sex-based considerations in the choice for a TLR9 or TLR7/8 agonist to arm the sentinel lymph node in early-stage melanomaJessica C L Notohardjo, Elisa C Toffoli, Tara Muijlwijk, et al.
Pageof 4